Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Zhejiang Jiuzhou Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baoying Resources Select Equity Fund
1,934,280
0.24%
-12,739,799
0.57%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
731,570
0.09%
0
0%
07/31/2018
515,340
0.06%
-217,800
0.19%
12/31/2017
195,120
0.02%
195,120
0.14%
12/31/2017
187,357
0.02%
-192,240
0.15%
12/31/2017
Lion Equity Fund
52,020
0.01%
52,020
0.01%
12/31/2017
44,280
0.01%
21,420
0.01%
12/31/2017
8,280
0%
8,280
0.01%
12/31/2017
Da Cheng Strategy Return Equity Fund
180
0%
0
0%
12/31/2017
0
0%
-426,181
0%
12/31/2017

About Zhejiang Jiuzhou Pharmaceutical Co.

View Profile
Address
99 Waisha Road
Taizhou Zhejiang 318000
China
Employees -
Website http://www.jiuzhoupharma.com
Updated 07/08/2019
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua in 1973 and is headquartered in Taizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.